Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Advocacy group asks Congress for $377M increase in funds for the FDA
The Alliance for a Stronger FDA said the increase is necessary to pay salaries and cover the organization's ballooning operational expenses.
FDA clears advanced AI model for predicting heart failure risk
The new algorithm from Implicity evaluates implantable device data and monitors patients for changes that suggest they could experience severe heart failure symptoms in the near future. It was designed to alert clinicians up to weeks in advance.
Maryland enacts sweeping ban on noncompetes for all healthcare professionals
The new law will ban noncompetes in the state for all healthcare workers who provide care, including veterinarians and veterinary technicians.
About that bipartisan $32B ‘roadmap’ for AI policy: What’s in it for healthcare?
This week Washington took a major step toward nailing down a solid game plan on federal AI spending for everything outside of defense.
FDA set to evaluate use of ‘ecstasy’ for treating PTSD
The party drug could soon be prescribed, in conjunction with psychological interventions, as a treatment for mental health disorders.

New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen among this important specialty.

Exploring diversity, compensation among academic cardiothoracic surgeons

New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen in this important specialty.

May 8, 2023

'Burdensome' Medicare Advantage prior authorization requirements cause delays or denials at 97% of practices

A new Medical Group Management Association report details how the problematic policies are negatively impacting patient care.

May 5, 2023

CDC centers for disease control at HIMSS 2023.

CDC director announces her resignation from the agency

News of the CDC director’s departure comes on the same day as an announcement made by the World Health Organization declaring the end of the COVID global health emergency.

May 5, 2023

New CMS code could pave the way for coverage of virtual reality-based treatments

The determination places the device under the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) benefit category.

May 3, 2023

cardiologist doctor physician patient black diverse hypertension

Q&A: Why the future of physician payments is looking brighter

Health Exec caught up with Claire Ernst from MGMA to learn more about the possibility of physician payments being tied to inflation in the future.

May 1, 2023

The FDA has cleared tirzepatide (Mounjaro) from Eli Lilly, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1) for improving glycemic control among adults with type 2 diabetes.

Eli Lilly targets FDA approval for weight loss medication

Tirzepatide, sold under the name Mounjaro, is among a handful of drugs with big buzz for their weight loss results, and approval for obesity could be a huge revenue source for Eli Lilly in the future.

April 28, 2023

CMS to punish hospitals sooner for price transparency noncompliance

Several studies have found that compliance is low with the government's new price transparency regulations. CMS hopes these newly announced changes can make a difference.

April 27, 2023

Supreme Court upholds full access to abortion pill

The Supreme Court issued a stay on April 21 that keeps mifepristone on the market without restrictions––for now.

April 24, 2023

Around the web

AI in Healthcare

About that bipartisan $32B ‘roadmap’ for AI policy: What’s in it for healthcare?

This week Washington took a major step toward nailing down a solid game plan on federal AI spending for everything outside of defense.

Cardiovascular Business

FDA announces new recall of delivery catheters after patient’s death

The recall includes specific lots of five different medical devices used to treat stroke and other neurovascular diseases.

Cardiovascular Business

FDA warns against use of troubled heart devices, citing ‘continued concerns’ after multiple recalls

The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible.